Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-06

Clinical Trial Update: Natural History of Anthrax: a Study of Primary Infected, Recovered, and Exposed Individuals (SPoRE); and Evaluation of AVA-Vaccinated Recipients

View source ↗

Summary

Clinical trial update for the SPoRE natural history study of anthrax and an evaluation of AVA-vaccinated recipients. Sponsored by NIAID, with the study currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AVA (Anthrax Vaccine Adsorbed) (Anthrax vaccine adsorbed)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Anthrax, Bacillus Infections | Status: RECRUITING